NSERecord Date7h ago · 25 Sept 2026, 11:23 am
Record Date
Natco Pharma Limited · NATCOPHARM
✦ AI SummaryFundraise
Natco Pharma Limited has announced the record date for its rights issue as October 1, 2026, as per Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Natco Pharma Limited has informed the Exchange that Record date for the purpose of Rights is 01-Oct-2026.
Attachments (1)
📄pdf
Download →
NATCOPHARM_25092026112301_RecordDateIntimation.pdf
View document text
September 25, 2026
Corporate Relationship Department The Manager – Listing
M/s. BSE Ltd. M/s. National Stock Exchange of India Ltd.
Mumbai – 400 001. MUMBAI – 400 051.
Scrip Code: 524816 Scrip Code: NATCOPHARM
Sub:- Intimation of record date pursuant to Regulation 42 of SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015
Ref: Outcome of the Board meeting intimated vide letter dated September 25, 2026
Dear Sir/Madam,
Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, we wish to inform you that the Board of Directors of the Company at
their meeting held today has fixed the Record date for the Rights Issue of the equity shares
as Thursday, 1st October, 2026 to determine the shareholders who will be eligible to
receive the Rights Entitlements under the Rights Issue.
Kindly take the same on record.
Thanking you
Yours faithfully,
For NATCO Pharma Limited
Ch. Venkat Ramesh
Company Secretary &
Compliance Officer